January 8, 2026 – TheNewswire - Vancouver, British Columbia, Canada – Neurothera Labs Inc. (TSXV: NTLX) (“Neurothera” or the “Company”), a clinical-stage biotech company and a majority-owned subsidiary of SciSparc Ltd. (Nasdaq: SPRC), is pleased to announce the results of its annual and special meeting of shareholders (“AGM”) held today. All of the nominee directors listed in Neurothera’s management information circular dated December 4, 2025 (the “Circular”) were elected as directors. Furthermore, shareho ...